Does the media favor AGL or HIMS?

In the previous week, Hims & Hers Health had 17 more articles in the media than Agilon Health. MarketBeat recorded 20 mentions for Hims & Hers Health and 3 mentions for Agilon Health. Hims & Hers Health's average media sentiment score of 0.57 beat Agilon Health's score of 0.43 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hims & Hers Health 9 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Positive

Does the media prefer AGL or SHC?

In the previous week, Agilon Health and Agilon Health both had 3 articles in the media. Sotera Health's average media sentiment score of 1.10 beat Agilon Health's score of 0.43 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sotera Health 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AGL or CAI?

In the previous week, Caris Life Sciences had 2 more articles in the media than Agilon Health. MarketBeat recorded 5 mentions for Caris Life Sciences and 3 mentions for Agilon Health. Caris Life Sciences' average media sentiment score of 0.45 beat Agilon Health's score of 0.43 indicating that Caris Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Caris Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Is RDNT or AGL more profitable?

RadNet has a net margin of -0.66% compared to Agilon Health's net margin of -6.09%. RadNet's return on equity of 2.77% beat Agilon Health's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% Agilon Health -6.09% -146.03% -24.55%

Does the media refer more to RDNT or AGL?

In the previous week, RadNet had 1 more articles in the media than Agilon Health. MarketBeat recorded 4 mentions for RadNet and 3 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.43 beat RadNet's score of 0.40 indicating that Agilon Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to AGL or BLLN?

In the previous week, Agilon Health and Agilon Health both had 3 articles in the media. Billiontoone's average media sentiment score of 0.81 beat Agilon Health's score of 0.43 indicating that Billiontoone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Billiontoone 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Agilon Health (AGL) Competitors

$91.47 -0.81 (-0.88%)

As of 02:54 PM Eastern

Compare

AGL vs. HIMS, SHC, CAI, RDNT, and BLLN

Should you buy Agilon Health stock or one of its competitors? MarketBeat compares Agilon Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Agilon Health include Hims & Hers Health (HIMS), Sotera Health (SHC), Caris Life Sciences (CAI), RadNet (RDNT), and Billiontoone (BLLN). These companies are all part of the "healthcare" industry.

How does Agilon Health compare to Hims & Hers Health?

Agilon Health (NYSE:AGL) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

In the previous week, Hims & Hers Health had 17 more articles in the media than Agilon Health. MarketBeat recorded 20 mentions for Hims & Hers Health and 3 mentions for Agilon Health. Hims & Hers Health's average media sentiment score of 0.57 beat Agilon Health's score of 0.43 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hims & Hers Health	9 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Positive

Agilon Health currently has a consensus price target of $58.73, indicating a potential downside of 35.52%. Hims & Hers Health has a consensus price target of $28.70, indicating a potential upside of 2.98%. Given Hims & Hers Health's higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

Hims & Hers Health has a net margin of -0.56% compared to Agilon Health's net margin of -6.09%. Hims & Hers Health's return on equity of 6.10% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Hims & Hers Health	-0.56%	6.10%	1.52%

Hims & Hers Health has lower revenue, but higher earnings than Agilon Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.26	-$391.35M	-$21.56	N/A
Hims & Hers Health	$2.35B	2.75	$128.37M	-$0.09	N/A

63.5% of Hims & Hers Health shares are held by institutional investors. 2.3% of Agilon Health shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Agilon Health has a beta of 3, suggesting that its share price is 200% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, suggesting that its share price is 137% more volatile than the broader market.

Summary

Hims & Hers Health beats Agilon Health on 11 of the 16 factors compared between the two stocks.

How does Agilon Health compare to Sotera Health?

Agilon Health (NYSE:AGL) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

Sotera Health has a net margin of 9.91% compared to Agilon Health's net margin of -6.09%. Sotera Health's return on equity of 39.73% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Sotera Health	9.91%	39.73%	7.05%

Sotera Health has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.26	-$391.35M	-$21.56	N/A
Sotera Health	$1.16B	3.84	$77.94M	$0.41	38.18

91.0% of Sotera Health shares are held by institutional investors. 2.3% of Agilon Health shares are held by company insiders. Comparatively, 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Agilon Health has a beta of 3, indicating that its share price is 200% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market.

Agilon Health presently has a consensus price target of $58.73, indicating a potential downside of 35.52%. Sotera Health has a consensus price target of $20.33, indicating a potential upside of 29.88%. Given Sotera Health's stronger consensus rating and higher probable upside, analysts clearly believe Sotera Health is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70

In the previous week, Agilon Health and Agilon Health both had 3 articles in the media. Sotera Health's average media sentiment score of 1.10 beat Agilon Health's score of 0.43 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sotera Health	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Sotera Health beats Agilon Health on 13 of the 15 factors compared between the two stocks.

How does Agilon Health compare to Caris Life Sciences?

Agilon Health (NYSE:AGL) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

Caris Life Sciences has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.26	-$391.35M	-$21.56	N/A
Caris Life Sciences	$812.03M	5.86	-$68.09M	-$7.61	N/A

In the previous week, Caris Life Sciences had 2 more articles in the media than Agilon Health. MarketBeat recorded 5 mentions for Caris Life Sciences and 3 mentions for Agilon Health. Caris Life Sciences' average media sentiment score of 0.45 beat Agilon Health's score of 0.43 indicating that Caris Life Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Caris Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Agilon Health currently has a consensus price target of $58.73, suggesting a potential downside of 35.52%. Caris Life Sciences has a consensus price target of $27.56, suggesting a potential upside of 63.83%. Given Caris Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe Caris Life Sciences is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20
Caris Life Sciences	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Caris Life Sciences has a net margin of 3.75% compared to Agilon Health's net margin of -6.09%. Caris Life Sciences' return on equity of 98.28% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Caris Life Sciences	3.75%	98.28%	48.87%

Summary

Caris Life Sciences beats Agilon Health on 12 of the 13 factors compared between the two stocks.

How does Agilon Health compare to RadNet?

RadNet (NASDAQ:RDNT) and Agilon Health (NYSE:AGL) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

77.9% of RadNet shares are owned by institutional investors. 5.6% of RadNet shares are owned by insiders. Comparatively, 2.3% of Agilon Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

RadNet currently has a consensus target price of $87.43, suggesting a potential upside of 65.21%. Agilon Health has a consensus target price of $58.73, suggesting a potential downside of 35.52%. Given RadNet's stronger consensus rating and higher possible upside, research analysts clearly believe RadNet is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20

RadNet has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Agilon Health has a beta of 3, indicating that its stock price is 200% more volatile than the broader market.

In the previous week, RadNet had 1 more articles in the media than Agilon Health. MarketBeat recorded 4 mentions for RadNet and 3 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.43 beat RadNet's score of 0.40 indicating that Agilon Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

RadNet has higher earnings, but lower revenue than Agilon Health. RadNet is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.04	-$18.65M	-$0.18	N/A
Agilon Health	$5.93B	0.26	-$391.35M	-$21.56	N/A

RadNet has a net margin of -0.66% compared to Agilon Health's net margin of -6.09%. RadNet's return on equity of 2.77% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Agilon Health	-6.09%	-146.03%	-24.55%

Summary

RadNet beats Agilon Health on 13 of the 17 factors compared between the two stocks.

How does Agilon Health compare to Billiontoone?

Agilon Health (NYSE:AGL) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

Agilon Health presently has a consensus price target of $58.73, suggesting a potential downside of 35.52%. Billiontoone has a consensus price target of $125.29, suggesting a potential upside of 31.92%. Given Billiontoone's stronger consensus rating and higher possible upside, analysts plainly believe Billiontoone is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has a net margin of 0.00% compared to Agilon Health's net margin of -6.09%. Billiontoone's return on equity of 0.00% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Billiontoone	N/A	N/A	N/A

Billiontoone has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.26	-$391.35M	-$21.56	N/A
Billiontoone	$305.11M	14.32	$7.45M	$0.55	172.68

In the previous week, Agilon Health and Agilon Health both had 3 articles in the media. Billiontoone's average media sentiment score of 0.81 beat Agilon Health's score of 0.43 indicating that Billiontoone is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Billiontoone beats Agilon Health on 11 of the 12 factors compared between the two stocks.

Get Agilon Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AGL vs. The Competition

Export

Metric	Agilon Health	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$1.52B	$8.50B	$6.32B	$23.27B
Dividend Yield	N/A	1.76%	2.68%	4.09%
P/E Ratio	-4.24	21.72	21.14	30.98
Price / Sales	0.26	19.54	548.16	24.93
Price / Cash	N/A	12.89	27.44	19.43
Price / Book	11.92	5.09	9.92	4.73
Net Income	-$391.35M	$175.77M	$3.56B	$1.07B
7 Day Performance	6.06%	2.45%	2.25%	1.47%
1 Month Performance	N/A	N/A	N/A	1.01%
1 Year Performance	64.11%	5.65%	36.64%	28.17%

Agilon Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AGL Agilon Health	1.7504 of 5 stars	$91.47 -0.9%	$58.73 -35.8%	+65.0%	$1.53B	$5.93B	N/A	1,076
HIMS Hims & Hers Health	2.7595 of 5 stars	$23.71 -0.2%	$28.90 +21.9%	-54.0%	$5.41B	$2.35B	N/A	2,442
SHC Sotera Health	3.7796 of 5 stars	$15.66 flat	$20.33 +29.8%	+27.6%	$4.47B	$1.16B	38.20	3,000
CAI Caris Life Sciences	4.8276 of 5 stars	$15.55 flat	$27.56 +77.2%	N/A	$4.40B	$812.03M	N/A	1,846	Gap Up
RDNT RadNet	3.8063 of 5 stars	$54.40 flat	$87.43 +60.7%	-3.9%	$4.28B	$2.04B	N/A	11,264

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AGL) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilon Health (AGL) Competitors

AGL vs. HIMS, SHC, CAI, RDNT, and BLLN

How does Agilon Health compare to Hims & Hers Health?

Summary

How does Agilon Health compare to Sotera Health?

Summary

How does Agilon Health compare to Caris Life Sciences?

Summary

How does Agilon Health compare to RadNet?

Summary

How does Agilon Health compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agilon Health (AGL) Competitors

AGL vs. HIMS, SHC, CAI, RDNT, and BLLN

How does Agilon Health compare to Hims & Hers Health?

Does the media favor AGL or HIMS?

Do analysts recommend AGL or HIMS?

Is AGL or HIMS more profitable?

Which has higher valuation & earnings, AGL or HIMS?

Do institutionals and insiders hold more shares of AGL or HIMS?

Which has more risk & volatility, AGL or HIMS?

Summary

How does Agilon Health compare to Sotera Health?

Is AGL or SHC more profitable?

Which has better earnings & valuation, AGL or SHC?

Do insiders & institutionals believe in AGL or SHC?

Which has more volatility and risk, AGL or SHC?

Do analysts recommend AGL or SHC?

Does the media prefer AGL or SHC?

Summary

How does Agilon Health compare to Caris Life Sciences?

Which has preferable earnings and valuation, AGL or CAI?

Does the media refer more to AGL or CAI?

Do analysts recommend AGL or CAI?

Is AGL or CAI more profitable?

Summary

How does Agilon Health compare to RadNet?

Do insiders and institutionals have more ownership in RDNT or AGL?

Do analysts recommend RDNT or AGL?

Which has more risk and volatility, RDNT or AGL?

Does the media refer more to RDNT or AGL?

Which has higher valuation and earnings, RDNT or AGL?

Is RDNT or AGL more profitable?

Summary

How does Agilon Health compare to Billiontoone?

Do analysts rate AGL or BLLN?

Is AGL or BLLN more profitable?

Which has higher earnings & valuation, AGL or BLLN?

Does the media refer more to AGL or BLLN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools